ARCHIVES

Ibrutinib Increases OS, PFS Versus Ofatumumab in Phase III

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

CHOP Evaluation Plan In Jan. 22 Issue

January 15, 1982

In Brief: ACCC Honors Henry Lynch; Gunderson Names Chair, Mayo Oncology Department

October 11, 1996

In Brief: HEW Clamps Down On Former Employees Hired To Go After Jobs They Had Helped Develop

May 3, 1974

In Brief: Schmidt Asks NCI Grantees, Contractors To tell Him How They Waste Cancer Money

December 13, 1974

Senate Bill Includes $10 Billion for NIH

February 6, 2009

Cancer Leadership Council letter calls for permanent leadership of NCI and FDA.

November 23, 2005